Vital Care Express

library_booksAll News

Page 3 of 3

search

KRAS-Targeted Vaccine Shows Early Promise Against Pancreatic Cancer

KRAS vaccine sparks durable immune response in high-risk pancreatic cancer trial

FDA Approves First Gene Therapy for Young Children with Sickle Cell Disease

FDA clears Casgevy gene therapy for kids as young as 2 with sickle cell

Kyverna Files for the First CAR-T Therapy in an Autoimmune Disease

Kyverna starts FDA filing for CAR-T in stiff-person syndrome

Study Uncovers Autoantibody Immune Defect Behind Severe COVID-19

Pre-existing B-cell autoantibodies linked to severe COVID-19 risk

Creatine May Boost Immune Cells and Slow Tumor Growth, New Study Finds

Study links creatine to stronger dendritic cells and slower tumors

FDA Approves Revtorpyk (gedatolisib): First Targeted Option for PIK3CA Wild-Type Breast Cancer

New Breast Cancer Drug Targets the PIK3CA Wild-Type Gap

Prostate Cancer Focal Therapy Matches Surgery on Survival With Far Fewer Side Effects

10-year study finds focal therapy matches surgery with fewer side effects

Neurologists Warn Ozempic and Wegovy May Speed ALS Decline

Doctors flag a hidden GLP-1 risk for people with ALS

Vaping in Decline as Young Australians Shift to Oral Nicotine Pouches

Young Australians Pivot to Oral Nicotine as Vaping Rates Fall

FDA Approves Lipfendra (enlicitide): First Oral PCSK9 Inhibitor Pill to Lower Cholesterol

FDA approves Lipfendra, the first oral PCSK9 cholesterol pill

Renewed $80 Million Grant Accelerates Exceptional Longevity Research

New $80 Million NIH Funding Boosts Global Longevity Study